Introduction {#sec1}
============

Small-molecule fluorophores are fundamental tools for biological research.^[@ref1],[@ref2]^ The century-old^[@ref3],[@ref4]^ rhodamine dyes remain the most useful class of small-molecule fluorophores and serve as scaffolds for a variety of useful imaging probes including biomolecule labels, cellular stains, and environmental indicators.^[@ref5],[@ref6]^ This broad utility can be attributed to three key aspects of rhodamine dyes:^[@ref7]−[@ref20]^ (i) exceptional brightness and photostability; (ii) a broad palette of spectral properties accessed through straightforward structural modifications; and (iii) the equilibrium between the colorless, nonfluorescent lactone (L) and the colored, fluorescent zwitterion (Z; equilibrium constant: *K*~L--Z~). Tuning *K*~L--Z~ lower---toward the lipophilic nonfluorescent lactone form---can improve cell-permeability^[@ref20]^ and yield "fluorogenic" ligands,^[@ref14],[@ref16],[@ref20]−[@ref24]^ molecules that show substantial increases in absorption and fluorescence upon binding their cognate biomolecular targets.

The inherent fluorescence increase of fluorogenic ligands is particularly useful for biological imaging as such compounds remain quiescent until bound to their target, making them universal platforms for imaging and sensing.^[@ref25]^ This property can avoid the need to wash out excess ligand^[@ref20]^ and allow exchange of labels to circumvent photobleaching.^[@ref26]^ Many useful fluorogenic ligands exploit solvatochromism,^[@ref27],[@ref28]^ pH sensitivity,^[@ref29],[@ref30]^ photoinduced electron transfer (PeT),^[@ref31]^ or quencher ejection^[@ref32]^ to translate the binding event into a change in fluorescence intensity. Recently, the tetramethyl-Si-rhodamine (SiR, **1**; [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a) has emerged as a remarkably versatile fluorogenic dye, demonstrated first by Johnsson and co-workers.^[@ref14]^ Compound **1** exhibits far-red wavelengths with an absorption maximum (λ~abs~) of 643 nm, a fluorescence emission maximum (λ~em~) of 662 nm, a modest fluorescence quantum yield (*Φ* = 0.41, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), and excellent photostability. An important feature of SiR-based ligands is the relatively low *K*~L--Z~ value (0.0034), which means the dye preferentially adopts the nonfluorescent lactone in aqueous solution ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a). This results in a lower extinction coefficient in aqueous solution (*ε*~w~ = 28 200 M^--1^ cm^--1^) but makes SiR-based ligands highly cell-permeable due to the increased fraction of the lipophilic lactone. The lower *K*~L--Z~ also makes SiR compounds fluorogenic as binding to biomolecular targets often shifts the equilibrium toward the fluorescent zwitterionic form ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b).

![Fluorogenicity of rhodamines. (a) Lactone--zwitterion equilibrium of SiR (**1**). (b) Mechanism of improved cell-permeability and fluorogenicity of **1**. (c) Structures of Janelia Fluor dyes **2**--**7**. (d) Absorption at λ~abs~ vs SDS concentration for **1** and **2** in 20 mM Na~2~HPO~4~, pH 7.0; error bars show ± s.e.m.; shading indicates \[SDS\] above the critical micelle concentration (c.m.c.).^[@ref36]^ (e) Change in fluorescence over the basal fluorescence (Δ*F*/*F*~0~) of HaloTag ligands **1**~**HTL**~--**10**~**HTL**~ upon labeling purified HaloTag protein vs the *K*~L--Z~ of the corresponding free dyes **1**--**10**; solid line indicates a linear fit (*R*^2^ = 0.90); shading indicates Δ*F*/*F*~0~ = 5--10 and *K*~L--Z~ = 10^--2^--10^--3^.](oc9b00676_0001){#fig1}

###### Properties of Rhodamine Dyes
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The initial development of SiR-based labels focused on fluorogenic ligands for genetically encoded self-labeling tags like the HaloTag and the SNAP-tag^[@ref14]^ but soon expanded to stains for endogenous structures like microtubules, F-actin, and DNA,^[@ref22]−[@ref24]^ as well as sensors for disparate analytes.^[@ref12],[@ref33],[@ref34]^ The cell-permeability, brightness, photostability, and far-red wavelengths of SiR ligands have enabled advanced imaging experiments using structured illumination microscopy (SIM) and stimulated emission depletion (STED) imaging.^[@ref14]^ The low *K*~L--Z~ of SiR also spurred the development of hydroxymethyl (HM) derivatives of SiR that spontaneously blink under physiological conditions and are useful for single-molecule localization microscopy (SMLM).^[@ref35]^ In another extension, our laboratory discovered that replacing the *N*,*N*-dimethylamino groups in fluorophores with four-membered azetidine rings was a general strategy to improve properties. Applying this strategy to SiR yielded a brighter and more fluorogenic dye: "Janelia Fluor" 646 (JF~646~, **2**; λ~abs~/λ~em~ = 646 nm/664 nm, *ε*~w~ = 5000 M^--1^ cm^--1^, *Φ* = 0.56, *K*~L--Z~ = 0.0012).^[@ref16]^ We could fine-tune this Si-rhodamine by incorporating 3-fluoroazetidine into the structure, yielding JF~635~ (**3**, λ~abs~/λ~em~ = 635 nm/652 nm, *ε*~w~ ≈ 400 M^--1^ cm^--1^, *Φ* = 0.54), which exhibited a low *K*~L--Z~ value (\<0.0001) and high fluorogenicity. This universal approach could be applied to carborhodamine and standard oxygen-containing rhodamine scaffolds to yield bright fluorescent and fluorogenic dyes across the visible spectrum (**4**--**7**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).^[@ref16],[@ref20]^

We set out to expand the palette of fluorogenic molecules with the goal of creating a green-emitting version of SiR. We first investigated the relationship between *K*~L--Z~ of dyes **1**--**7** and the fluorogenicity of their respective HaloTag ligands to determine a quantitative framework for the rational design of new fluorogenic rhodamine dyes. We discovered that the *K*~L--Z~ is sufficient to predict fluorogenicity, and we determined that *K*~L--Z~ \< 10^--2^ was an appropriate threshold for the design of highly fluorogenic ligands, validating this with the known Si-rhodamine 110 (SiR~110~, **8**). We next turned to the oxygen-containing rhodamine scaffold, first preparing derivatives of a tuned dye, JF~552~ (**9**), and then the rationally designed fluorophore JF~526~ (**10**). This dye shows similar fluorogenicity to SiR, allows the creation of fluorogenic labels and stains, and can be further modified to a spontaneously blinking derivative that enables facile localization microscopy in cells.

Results and Discussion {#sec2}
======================

Mechanism of SiR/JF~646~ Fluorogenicity {#sec2.1}
---------------------------------------

In previous studies, the fluorogenicity of ligands based on SiR and other rhodamines was attributed, in part, to the formation of weakly fluorescent aggregates.^[@ref14],[@ref37]^ The key evidence for this mechanism was the large increase in absorption that occurred when the detergent sodium dodecyl sulfate (SDS) was added to aqueous solutions of SiR-based compounds, presumably disaggregating the dye. We investigated this phenomenon and found it was detergent-specific; incubation of SiR (**1**) and JF~646~ (**2**) with commonly used laboratory detergents showed absorption increases only in the presence of SDS ([Figure S1a](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)). We further characterized the interaction between the Si-rhodamine dyes **1** and **2** and SDS by measuring the absorption of **1** or **2** versus \[SDS\] and observed the absorption increase only above the critical micelle concentration (c.m.c.) of SDS ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}d). These results suggest another mechanism for this observed increase in absorption, where dyes **1** and **2** interact with the negatively charged SDS-micelle surface, thereby stabilizing the zwitterionic form and giving the observed increase in absorption. This is further supported by the bathochromic shift in λ~abs~ observed for **1** and **2** in the presence of SDS ([Figure S1b,c](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)), which is characteristic for rhodamine--SDS-micelle complexes.^[@ref38]^ These data reveal a problem with the use of SDS solutions to determine the spectral properties of fluorogenic dyes as the measurement is strongly concentration- and dye-dependent ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}d). We instead use a solution of strong acid in alcohol solvents to shift the equilibrium to the open form by protonation of the *o*-carboxyl group. This decades-old procedure^[@ref39],[@ref40]^ allows estimation of the maximal extinction coefficient (ε~max~) and determination of *K*~L--Z~ ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)).

On the basis of these results, we hypothesized that the low *K*~L--Z~ value was the primary driver behind the fluorogenicity of SiR and similar fluorogenic rhodamines. In this mechanism, the fluorophores preferentially adopt the colorless lactone form in solution, largely independent of concentration, dye structure, or ligand moiety. Binding to the biomolecule shifts the equilibrium to the fluorescent zwitterionic form through steric interactions and other changes to the local chemical environment. Aggregation of such compounds can still occur, particularly for high concentrations of dyes that prefer the lipophilic lactone form, but this is a consequence of the low *K*~L--Z~ and not the causal element behind the observed fluorogenicity. To test this premise, we examined the relationship between *K*~L--Z~ for a series of fluorescent dyes (**1**--**7**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) and the increase in fluorescence of the corresponding HaloTag ligands upon conjugation to purified HaloTag protein (**1**~**HTL**~--**7**~**HTL**~, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}e, [Figure S1d](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)). The *K*~L--Z~ was determined using ε values measured in 1:1 dioxane:water (*ε*~dw~) to ensure a broad distribution of values.^[@ref20]^ We found an inverse relationship between *K*~L--Z~ and fluorogenicity, showing that *K*~L--Z~ is sufficient to predict the increase in fluorescence of different rhodamine dyes upon binding the same target. This increase in fluorescence is primarily driven by a rise in absorption; chromogenicity is correlated with both *K*~L--Z~ and fluorogenicity ([Figure S1e,f](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)). This trend holds across different rhodamine scaffolds including Si-rhodamines (**1**--**3**), carborhodamines (**4** and **5**), and classic, oxygen-containing rhodamines (**6** and **7**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c). This inverse relationship yielded a simple rubric: a dye with *K*~L--Z~ = 10^--2^--10^--3^ should yield a HaloTag ligand with 5--10-fold fluorogenicity ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}e).

Si-Rhodamine 110 {#sec2.2}
----------------

In previous work, we developed strategies to fine-tune the properties of rhodamines by incorporating substituted azetidines into the dye structure.^[@ref20]^ In particular, we developed the bright, fluorogenic carborhodamine JF~585~ (**5**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c; λ~abs~/λ~em~ = 585 nm/609 nm, *Φ* = 0.78) by replacing the azetidine rings in JF~608~ (**4**; λ~abs~/λ~em~ = 608 nm/631 nm, *Φ* = 0.67) with 3,3-difluoroazetidine; the *K*~L--Z~--fluorogenicity trend holds for these dyes ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}e). As an alternative strategy to create orange-emitting fluorogenic dyes, we investigated the Si-containing analogue of rhodamine 110 (**8**), which has been described as a scaffold for fluorogenic enzyme substrates in the patent literature^[@ref41]^ but has not been used as a fluorescent label in cellular experiments. We synthesized this compound using the Pd-catalyzed cross-coupling of the Si-fluorescein ditriflate (**11**) with *t*-butyl carbamate followed by deprotection with TFA ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a).^[@ref16],[@ref42]^ Compound **8** exhibited λ~max~/λ~em~ = 587 nm/609 nm, representing a ∼50 nm hypsochromic shift relative to SiR (**1**; λ~abs~/λ~em~ = 643 nm/662 nm, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}); we named this dye Si-rhodamine 110 (SiR~110~). It has an increased fluorescence quantum yield (*Φ* = 0.53) compared to SiR (*Φ* = 0.41, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), but a comparable *K*~L--Z~ = 0.0043.

![Synthesis and testing of SiR~110~. (a) Synthesis of SiR~110~ (**8**). (b) Synthesis of SiR~110~--HaloTag ligand (**8**~**HTL**~). (c) Absorption spectra of **8**~**HTL**~ (5 μM) in the absence (black) or presence (orange) of excess HaloTag protein. (d) Confocal image of U2OS cells expressing histone H2B--HaloTag fusion protein and labeled with **8**~**HTL**~. Scale bar: 20 μm. (e) Relative photostability of **8**~**HTL**~ and JF~585~--HaloTag ligand (**5**~**HTL**~) in live cells.](oc9b00676_0002){#fig2}

On the basis of our *K*~L--Z~ versus fluorogenicity relationship ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}e), we predicted that ligands based on **8** would be fluorogenic. This was a noteworthy test of our hypothesis since SiR~110~ has similar *K*~L--Z~ values to SiR but a different structure---lacking the four hydrophobic CH~3~ groups in **1**. We prepared the SiR~110~--HaloTag ligand (**8**~**HTL**~, [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b) starting from the 6-carboxy-Si-fluorescein ditriflate methyl ester (**13**).^[@ref43]^ Cross-coupling afforded the Boc-protected SiR~110~**14**, which was saponified to yield free acid **15**. Formation of the *N*-hydroxysuccinimidyl ester *in situ*, amidation with the HaloTag ligand (**16**), and deprotection with TFA yielded **8**~**HTL**~. We observed a 7-fold increase in absorption and Δ*F*/*F*~0~ = 9 after conjugation of **8**~**HTL**~ to HaloTag protein, slightly higher than SiR--HaloTag ligand (**1**~**HTL**~; *ΔF*/*F*~0~ = 5; [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c, [Figure S1d](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)) and in line with the *K*~L--Z~ trend ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}e). This dye was an excellent label for live-cell imaging experiments ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}d) and showed higher photostability than our previously described orange-emitting fluorogenic JF~585~--HaloTag ligand (**5**~**HTL**~, [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}e). These results further support our hypothesis that a low *K*~L--Z~ value is a primary factor for rhodamine fluorogenicity.

Janelia Fluor 552 {#sec2.3}
-----------------

We then turned to the standard, oxygen-containing rhodamine scaffold exemplified by JF~549~ (**6**, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c; λ~abs~/λ~em~ = 549 nm/571 nm, *Φ* = 0.88). Creating a fluorogenic rhodamine is challenging since this dye type strongly prefers the fluorescent zwitterionic form; JF~549~ exhibits a high *K*~L--Z~ = 3.5, which is \>10^2^-fold higher than the apparent *K*~L--Z~ threshold for a fluorogenic ligand ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}e). Incorporation of 3,3-difluoroazetidine motifs into the JF~549~ structure yields JF~525~ (**7**), which shows a lower *K*~L--Z~ = 0.068 and elicits ∼25 nm hypsochromic shift with similar brightness (λ~max~/λ~em~ = 525 nm/549 nm, *Φ* = 0.91; [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). This *K*~L--Z~ tuning is insufficient to achieve substantial fluorogenicity although the JF~525~--HaloTag ligand (**7**~**HTL**~) exhibits higher cell-permeability than the JF~549~--HaloTag ligand (**6**~**HTL**~)^[@ref20]^ and can cross the blood--brain barrier.^[@ref44]^ Since we exhausted the available substitutions on the azetidine ring with JF~525~, we sought a complementary approach for further modulating *K*~L--Z~. We recently reported a JF~549~ analogue with fluorine atoms installed at the 2′ and 7′ positions on the xanthene ring. This modification reduced the *K*~L--Z~ by 5-fold (*K*~L--Z~ = 0.70) with only a minor shift in spectral properties (λ~abs~/λ~em~ = 552 nm/575 nm, *Φ* = 0.83; [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).^[@ref19]^ The resulting dye, Janelia Fluor 552 (JF~552~; **9**), is of particular interest because it could show improved cell-permeability relative to JF~549~ and could be further modified to create a fluorogenic rhodamine.

We aimed to develop a general synthetic strategy for JF~552~ derivatives that would also allow late-stage incorporation of different azetidinyl functionality. Unfortunately, our standard Pd-catalyzed cross-coupling approach for rhodamines^[@ref42],[@ref45]^ gave low yield (\<5%) when starting with 2′,7′-difluorofluorescein ditriflate due to the instability of the *o*-fluorophenyl triflate groups (data not shown). To circumvent this problem, we devised an alternative synthesis starting with 3-bromo-4-fluorophenol (**17**, [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}a). Acid-mediated condensation of **17** and phthalic anhydride (**18**) yielded dibromofluoran **19**. Pd-catalyzed cross-coupling with azetidine (**20**) provided JF~552~ (**9**). To introduce a carboxyl group for bioconjugation, we condensed phenol **17** and with trimellitic anhydride (**21**) to give an isomeric mixture; crystallization from 9:1 toluene:pyridine yielded the 6-carboxy isomer **22**. This was protected as the *t*-butyl ester using *N*,*N*-dimethylformamide di-*t*-butyl acetal (**23**) to yield **24**, followed by Pd-catalyzed cross-coupling with azetidine (**20**) to provide 6-carboxy-JF~552~*t*-butyl ester (**25**). Deprotection of **25** with TFA yielded carboxylic acid **26**, and subsequent conjugation to the HaloTag ligand amine (**16**) gave JF~552~--HaloTag ligand **9**~**HTL**~ ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}b). On the basis of these results, we briefly attempted to transform 2′,7′-difluorofluorescein ditriflates to their respective dibromofluorans using Ru catalysts.^[@ref46]^ This reaction was successful for the synthesis of dibromide **19** but gave poor yields of *t*-butyl ester **24** (data not shown).

![Syntheses of JF~552~ and JF~549~ Derivatives: (a) Synthesis of **9**, (b) Synthesis of **9**~**HTL**~, and (c) Synthesis of **6**~**TMP**~ and **9**~**TMP**~](oc9b00676_0008){#sch1}

We then evaluated JF~552~ ligands as cell-permeable fluorescent labels, comparing the JF~552~--HaloTag ligand (**9**~**HTL**~) to JF~549~--HaloTag ligand (**6**~**HTL**~, [Figure S1d](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)) in yeast expressing histone H2A.Z--HaloTag protein fusion. Although **6**~**HTL**~ showed relatively poor labeling ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a), the **9**~**HTL**~ molecule showed a high fluorescence signal from the yeast nuclei under the same imaging conditions ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}b). This result is expected on the basis of the smaller *K*~L--Z~ of JF~552~, which should improve cell-permeability. We also synthesized the trimethoprim (TMP) conjugates of JF~549~ and JF~552~ (**6**~**TMP**~ and **9**~**TMP**~) by reacting the 6-carboxy derivatives of these dyes (**26** and **27**, respectively) with the amino-TMP **28** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}c). TMP conjugates selectively bind to *Escherichia coli* dihydrofolate reductase (eDHFR), and this labeling strategy can be used for live-cell imaging.^[@ref47]^ We expressed histone H2B--eDHFR fusions in U2OS cells and labeled with **6**~**TMP**~ or **9**~**TMP**~. Nuclei labeled with JF~552~-based **9**~**TMP**~ were 8-fold brighter than cells labeled with **6**~**TMP**~, giving images with higher signal-to-background ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}c,d). These results support our hypothesis that even modest decreases in *K*~L--Z~ can improve cell-permeability across different cell-types and labeling strategies.

![JF~552~ ligands show improved cell-permeability. Overlay of fluorescence and bright-field images of yeast cells expressing a histone H2A.Z--HaloTag fusion protein and labeled with **6**~**HTL**~ (a) or **9**~**HTL**~ (b). Overlay of fluorescence and bright-field images of U2OS cells expressing histone H2B--eDHFR fusion protein and labeled with **6**~**TMP**~ (c) or **9**~**HTL**~ (d). Scale bars for all images: 5 μm.](oc9b00676_0003){#fig3}

Janelia Fluor 526 {#sec2.4}
-----------------

We then combined the structural modifications of **7** (*K*~L--Z~ = 0.068) and **9** (*K*~L--Z~ = 0.70), positing that the two complementary alterations could additively shift the *K*~L--Z~ \< 10^--2^, thus yielding a fluorogenic rhodamine. To prepare the free dye we used Pd-catalyzed cross-coupling to attach 3,3-difluoroazetidine (**29**) to dibromide **19** yielding the hexafluorinated rhodamine **10** ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a). We termed the resulting compound Janelia Fluor 526 (JF~526~, λ~abs~/λ~em~ = 526 nm/550 nm, *Φ* = 0.87), which exhibited the desired additive effect on the lactone--zwitterion equilibrium (*K*~L--Z~ = 0.0050; [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). We then synthesized the 6-carboxy derivative using a route akin to the JF~552~ ligands ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}b): cross-coupling of dibromide **24** with azetidine **29** to give *t*-butyl ester **30** followed by deprotection with TFA to give **31**. This compound could be coupled to amine-containing ligand moieties to yield JF~526~--HaloTag ligand (**10**~**HTL**~) and JF~526~--SNAP-tag ligand (**10**~**STL**~, [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b, [Scheme S1a](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)). We compared this with the previously described JF~525~--HaloTag ligand^[@ref20]^ (**7**~**HTL**~) *in vitro* and in live cells. Although **7**~**HTL**~ exhibited a modest \<2-fold increase of absorption upon conjugation to purified HaloTag protein, **10**~**HTL**~ exhibited a substantial 9-fold increase ([Figure S2a,b](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)), again following the *K*~L--Z~--fluorogenicity trend ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}e). JF~526~ showed superior signal-to-background compared to JF~525~ in "no-wash", live-cell imaging experiments using either the HaloTag ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}d,e) or SNAP-tag expressed as histone H2B fusion proteins (**10**~**STL**~ versus **7**~**STL**~, [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}f,g).

![Synthesis and no-wash imaging of JF~526~ ligands. Synthesis of JF~526~ (a) and JF~526~ (b) ligands. (c) Structures of JF~525~ and JF~526~--HaloTag and SNAP-tag ligands. Confocal images of COS7 cells expressing a histone H2B--HaloTag fusion protein and labeled with 500 nM JF~525~--HaloTag ligand (**7**~**HTL**~, d) or JF~526~--HaloTag ligand (**10**~**HTL**~, e). Confocal images of COS7 cells expressing histone H2B--SNAP-tag fusion protein and labeled with 1 μM JF~525~--SNAP-tag ligand (**7**~**STL**~, f) or JF~526~--SNAP-tag ligand (**10**~**STL**~, g). Scale bars for all images: 5 μm.](oc9b00676_0004){#fig4}

We then prepared other JF~526~ ligands ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b, [Scheme S1b--d](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)) to demonstrate the general utility of this dye for multicolor advanced microscopy experiments. On the basis of previous work with SiR (**1**), JF~646~ (**2**), and other dyes,^[@ref22]−[@ref24],[@ref48],[@ref49]^ we synthesized the following conjugates: JF~526~--Hoechst (**10**~**HST**~) to stain DNA, JF~526~--Taxol (**10**~**TXL**~) to image microtubules, and JF~526~--pepstatin A (**10**~**PEP**~) to visualize lysosomes ([Figures [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b and [5](#fig5){ref-type="fig"}a). **10**~**HST**~ showed a modest increase in absorption (\<2-fold) and a large increase in fluorescence quantum yield (10-fold) upon binding purified AT-rich DNA ([Figure S2c,d](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)), showing that chromogenicity can be magnified by other photophysical effects. The JF~526~--Taxol (**10**~**TXL**~) also showed increased fluorescence upon binding to polymerized tubulin *in vitro*; this fluorogenicity was comparable to that of "SiR-tubulin" (**1**~**TXL**~)^[@ref22]^ and higher than JF~525~--Taxol (**7**~**TXL**~; [Figure S2e--h and Scheme S1e](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)). Live-cell imaging with these compounds showed specific staining, enabling one-, two-, and three-color no-wash imaging experiments ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}b--d). We then used JF~526~ ligands in advanced microscopy. We performed two-color 3D-SIM^[@ref50]^ in live cells using JF~526~--pepstatin A (**10**~**PEP**~) and JF~646~--Hoechst^[@ref49]^ (**2**~**HST**~, [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}a). JF~526~ also enabled multicolor super-resolution STED microscopy^[@ref51]^ of microtubules using **10**~**TXL**~ depleted with 775 nm ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}b, [Figure S2i--k](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf)). Notably, the compatibility of JF~526~ with the standard 775 nm depletion line facilitated three-color live-cell STED imaging using JF~526~--Taxol (**10**~**TXL**~, microtubules), JF~646~--SNAP-tag ligand (**2**~**STL**~) targeted to Sec61β (endoplasmic reticulum), and JF~585~--HaloTag ligand (**5**~**HTL**~) targeted to TOMM20 (mitochondria, [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}c). Finally, the JF~526~--pepstatin A (**10**~**PEP**~) could be used for live-cell, two-color lattice light-sheet microscopy^[@ref52]^ with **2**~**HST**~ ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}d).

![Extending the repertoire of JF~526~ ligands. (a) Structures of JF~526~ ligands. (b) Confocal image of live U2OS cells stained with JF~526~--Hoechst (**10**~**HST**~). (c) Confocal image of mouse primary hippocampal neurons stained with JF~526~--Taxol (**10**~**TXL**~) and JF~646~--Hoechst (**2**~**HST**~). (d) Confocal image of U2OS cells expressing histone-H2B--HaloTag fusion protein and labeled with JF~526~--pepstatin A (**10**~**PEP**~), JF~585~--HaloTag ligand (**5**~**HTL**~), and "SiR--tubulin" (**1**~**TXL**~). All images were acquired without washing. Scale bars: 5 μm.](oc9b00676_0005){#fig5}

![Advanced microscopy imaging using JF~526~. (a) Confocal and SIM images of mouse primary hippocampal neurons stained with **10**~**PEP**~ and JF~646~--Hoechst (**2**~**HST**~). (b) Confocal and STED microscopy images of U2OS cells stained with **10**~**TXL**~. (c) Three-color live-cell STED image of U2OS cells expressing Sec61β--SNAP-tag labeled with JF~646~--SNAP-tag ligand (**2**~**STL**~), TOMM20--HaloTag labeled with JF~585~--HaloTag ligand (**5**~**HTL**~), and microtubules stained with **10**~**TXL**~. (d) Lattice light-sheet microscopy image of U2OS cells stained with **10**~**PEP**~ and **2**~**HST**~. Scale bars for all images: 5 μm.](oc9b00676_0006){#fig6}

Hydroxymethyl JF~526~ {#sec2.5}
---------------------

The lactone--zwitterion equilibrium of rhodamine dyes can be further exploited for single-molecule localization microscopy (SMLM). Converting the *o*-carboxyl moiety in SiR to the more nucleophilic hydroxymethyl group elicits an additional shift to the closed form.^[@ref35],[@ref53]^ The resulting hydroxymethyl-SiR (HM-SiR, **32**) exists primarily in a colorless, nonfluorescent spiroether form but spontaneously switches to a transient, fluorescent form upon protonation at physiological pH ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}a). This blinking behavior enables facile SMLM imaging, bypassing the need for photoconvertible fluorescent proteins, photoactivatable dyes, or strongly reducing *d*STORM buffers.^[@ref54]^

![Localization microscopy with HM-JF~526~. (a) Blinking behavior of HM-SiR (**32**). (b) Synthesis of HM-JF~526~ NHS (**37**). Immunofluorescence images of tubulin labeled with a **37**--antibody conjugate: (c) SMLM image, (d) diffraction-limited image. (e) Transverse profiles of fluorescence intensity corresponding to boxed regions in parts c and d. Immunofluorescence images of TOMM20 labeled with a **37**--antibody conjugate: (f) SMLM image; (g) diffraction-limited image. (h) Transverse profiles of fluorescence intensity corresponding to boxed regions in parts f and g. Solid lines in parts e and h indicate Gaussian fits; numbers indicate the full width at half-maximum (fwhm) determined by the Gaussian fits of the SMLM (green) and diffraction-limited imaging (black). Scale bars for all images: 5 μm.](oc9b00676_0007){#fig7}

Given the similarity of the *K*~L--Z~ values for JF~526~ and SiR, we were curious if a hydroxymethyl derivative of JF~526~ would show comparable utility to **32** in SMLM. We devised an efficient, high-yielding approach to synthesize derivatives of hydroxymethyl JF~526~ (HM-JF~526~), leveraging our divergent synthesis of JF~526~ and the differential reactivity of carboxyl groups and lactones with borohydride reductants.^[@ref55]^ Treatment of dibromofluoran **22** with LiBH~4~ at ambient temperature selectively reduced the lactone to a cyclic ether leaving the 6-carboxy group intact, providing **33** in moderate yield (54%; [Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}b). Formation of 6-*t*-butyl ester with acetal **23** gave **34**, allowing Pd-catalyzed cross-coupling with **29**. The resulting 6-*tert*-butoxycarbonyl-HM-JF~526~ (**35**) can be deprotected to yield carboxylic acid **36** and then converted to amine-reactive *N*-hydroxysuccinimidyl ester **37** (HM-JF~526~ NHS).

To evaluate the performance of HM-JF~526~ in SMLM experiments we used **37** to label a goat-antimouse secondary antibody, followed by immunostaining of an anti-β-tubulin primary antibody in fixed cells. SMLM imaging in standard phosphate-buffered saline (pH 7.4) revealed that the HM-JF~526~ label showed spontaneous blinking behavior throughout the imaging session and did not require short-wavelength activation light ([Movie S1](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_002.avi)). Standard SMLM analysis transformed these movies into super-resolution images ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}c,d); the HM-JF~526~ label yielded 571 photons on average with a localization accuracy (σ) of 25 nm. The SMLM images showed fine structures of microtubules with a full width at half-maximum (fwhm) of 86 nm; diffraction-limited images had an fwhm of 253 nm ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}e). We also labeled mitochondria using an anti-TOMM20 primary antibody which gave SMLM images of mitochondria with improved resolution (fwhm = 143 nm) compared to diffraction-limited images (fwhm = 581 nm; [Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}f--h). HM-JF~526~ constitutes a new label for SMLM that is spectrally distinct from HM-SiR and compatible with standard immunolabeling protocols.

Conclusion {#sec3}
==========

Rhodamine dyes exist in equilibrium between a lipophilic, colorless lactone and a polar, fluorescent zwitterion. This property dictates many properties of rhodamines including cell-permeability and fluorogenicity. On the basis of the prototypical fluorogenic dye SiR (**1**) and the Janelia Fluor dyes (**2**--**7**), we showed that the equilibrium constant, *K*~L--Z~, is sufficient to predict fluorogenicity by comparing the *K*~L--Z~ of rhodamines and the change in fluorescence of their respective HaloTag ligands upon binding their protein target. We found an inverse relationship between these two parameters and developed a quantitative framework for developing new fluorogenic molecules: tuning *K*~L--Z~ between 10^--2^ and 10^--3^ gives ligands with fluorogenicity of 5--10-fold ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). This rubric was validated with the orange-emitting dye, SiR~110~ (**8**), which is fluorogenic and shows improved photostability compared to our previously described JF~585~ (**5**, [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}).

Our previous attempts to tune the *K*~L--Z~ of standard rhodamine dyes using 3,3-difluoroazetidine substituents transformed JF~549~ (**6**, *K*~L--Z~ = 3.5) to the highly bioavailable JF~525~ (**7**, *K*~L--Z~ = 0.068). Nevertheless, this decrease in *K*~L--Z~ was insufficient to meet the fluorogenic threshold of *K*~L--Z~ \< 10^--2^; ligands based on JF~525~ show low degrees of fluorogenicity. We used a complementary approach to further tune the *K*~L--Z~ by fluorinating the xanthene system. This yielded the highly cell-permeant JF~552~ (**9**) as an intermediary product ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}) and ultimately led to the fluorogenic rhodamine JF~526~ (**10**). Akin to SiR (**1**), JF~526~ is a versatile scaffold for fluorogenic ligands, including labels for genetically encoded self-labeling protein tags ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}) and stains for endogenous structures ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). These green-emitting ligands can be used in concert with red- and orange-emitting fluorogenic dyes,^[@ref14],[@ref16],[@ref20]^ allowing multicolor SIM and STED imaging in live cells ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). We further extended the utility of JF~526~ to SMLM by creating the spontaneously blinking derivative: HM-JF~526~ ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}).

Looking forward, our results demonstrate the importance of *K*~L--Z~ in the rational design of fluorogenic and spontaneously blinking rhodamines, regardless of the specific dye structure. This general rubric we uncovered should enable rational design of fluorogenic and spontaneously blinking dyes using other rhodamine variants, especially the exciting near-infrared derivatives containing phosphinate, phosphine oxide, or sulfone groups,^[@ref15],[@ref17],[@ref18]^ pushing advanced microscopy to longer wavelengths. This quantitative approach could be applied to fluoresceins and rhodols, which bear *o*-carboxy groups and have environmentally sensitive equilibria between fluorescent and nonfluorescent lactone forms.^[@ref13],[@ref19],[@ref56]−[@ref58]^ Finally, we posit that the environmental sensitivity of fluorogenic rhodamines can be exploited beyond preparing ligands for no-wash imaging experiments. Like other fluorogenic molecules,^[@ref59]−[@ref61]^ transduction of protein conformational changes into fluorescence modulations will provide new hybrid small-molecule:protein sensors for functional imaging inside living cells and organisms.

Safety Statement {#sec3.1}
----------------

No unexpected or unusually high safety hazards were encountered.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acscentsci.9b00676](http://pubs.acs.org/doi/abs/10.1021/acscentsci.9b00676).Methods for chemical synthesis, optical spectroscopy, and microscopy; and characterization data for all new compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_001.pdf))Movie S1: Time-lapse video of tubulin in fixed U2OS cells immunostained with HM-JF526 and excited with 561 nm laser light; no photoactivation laser was used; scale bar: 5 μm ([AVI](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.9b00676/suppl_file/oc9b00676_si_002.avi))
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